Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
49.04
+0.30 (+0.62%)
Streaming Delayed Price
Updated: 3:45 PM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,052,105
Open
48.84
Bid (Size)
49.04 (400)
Ask (Size)
49.05 (200)
Prev. Close
48.74
Today's Range
48.12 - 50.07
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
2.38%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.
↗
Today 5:30 EST
Both companies are betting on interest in weight loss pills.
Via
The Motley Fool
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report
↗
Today 5:21 EST
Via
Stocktwits
Performance
YTD
-6.4%
-6.4%
1 Month
-18.1%
-18.1%
3 Month
-2.4%
-2.4%
6 Month
-3.7%
-3.7%
1 Year
-41.4%
-41.4%
More News
Read More
Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs
↗
Today 4:23 EST
Via
Benzinga
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly
↗
February 11, 2026
Via
Stocktwits
Topics
Intellectual Property
The Greenland Gambit: Inside the Transatlantic Tariff Shock and the Future of Arctic Sovereignty
February 11, 2026
Via
MarketMinute
Topics
Bonds
Economy
Government
HIMS Stock Plunges 8 Straight Days: Is The GLP-1 Fallout Already Priced In?
↗
February 11, 2026
Via
Stocktwits
Disney Has Its Next CEO
↗
February 11, 2026
Via
The Motley Fool
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
↗
February 11, 2026
Via
The Motley Fool
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore
↗
February 11, 2026
Via
The Motley Fool
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know
↗
February 10, 2026
Via
The Motley Fool
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial
↗
February 10, 2026
Via
Stocktwits
Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains?
↗
February 10, 2026
Via
The Motley Fool
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
↗
February 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Lawsuit
Stocks
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why Novo Nordisk Stock Just Popped
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Why Hims & Hers Stock Just Got Destroyed
↗
February 09, 2026
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash
February 09, 2026
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains
↗
February 09, 2026
Via
Stocktwits
Topics
Lawsuit
Why Eli Lilly Stock Just Popped
↗
February 09, 2026
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Hims & Hers Shares Crater After Abrupt Oral Wegovy U-Turn
February 09, 2026
Via
MarketMinute
Topics
Earnings
Intellectual Property
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks
↗
February 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt
↗
February 08, 2026
Via
Stocktwits
Topics
Intellectual Property
Law Enforcement
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 49.04
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/12/26 03:45 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.